The Barcelona International Youth Science Challenge (BIYSC) is a singular programme run by the Catalunya-La Pedrera Foundation that seeks to bring together students with a passion for science and the best scientists in prestigious research centres in Catalonia.
IRB Barcelona participates in the BIYSC through the project “From DNA to protein related diseases”, which includes sessions about the different fields addressed at the institute.
Several media have picked up on the launch of the new biotechnology company Nostrum BioDiscovery, a joint initiative between IRB Barcelona and the Barcelona Supercomputing Center-National Supercomputing Center (BSC-CNS). Modesto Orozco, group leader of the Molecular Modelling and Bioinformatics lab at IRB Barcelona, will chair the new spin-off, which aims to launch new drugs and biotech molecules developed using computational simulation.
Nostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona and ICREA and supported by the Botín Foundation’s technology transfer programme.
The company boasts cutting-edge bioinformatics technologies to speed up the development and lower the cost of designing drugs—which are becoming increasingly more complex and expensive—and to further precision medicine.
Fierce BiotechIT, a biotechnology-specialized website, has written an article on the new European project, led by Modesto Orozco, which will inject 3€ million euros into 3-D genomics.
IRB Barcelona is to coordinate a Horizon2020 bioinformatics project that seeks to lay the groundwork for the emerging field of 3D genomics.
3D genomics provides information about the structures adopted by folded DNA inside a cell and about how they change over time and in response to alterations in cell environment. Modesto Orozco, the coordinator of the project says, “The 3D perspective will allow us to better relate changes in the genome with the corresponding diseases, because although 1D information is relevant, it falls short.”
Over three years, the project aims to provide a set of methods and integrated databases that can be used to store and process the data deriving from studies devoted to 3D genomics.
The European consortium comprises six international leading centres in method development and visualisation in 3D genomics.
Various media channels have commented on the launch of a DNA simulation tool developed by Modesto Orozco’s lab at IRB Barcelona, in collaboration with several international labs.
Published in Nature Methods, the work is available on an open-access basis through http://mmb.irbbarcelona.org/ParmBSC1/
The simulation method developed in Modesto Orozco’s laboratory allows the study—with unprecedented accuracy—of structural changes in DNA and of the interaction of DNA with proteins and drugs.
All the simulations and posterior analyses are kept in the first online tool developed to date dedicated to atomic level simulations of nucleic acids.
The platform is free of charge and available to the entire scientific community through the Spanish Institute of Bioinformatics and the European network ELIXIR-Excellerate.
In addition to other uses, the new method provides greater insight into how DNA is recognised by proteins that modify its function or by the drugs that bind to it to exert their therapeutic action, thereby furthering our understanding of the biological function of DNA.
Sharp Minds, a science dissemination blog, publishes an interview with Modesto Orozco about what drives him and his work at IRB Barcelona on bioinformatics and supercomputing -fields in which he is an international authority.
The National Bioinformatics Institute (INB) acts as the Spanish scientific node and coordinates the partner institutions. These comprises CNIO, CRG, UPF, BSC and IRB Barcelona